Oslo, April 7, 2010: OptiNose, a leader in nasal drug delivery systems, is pleased to announce the publication in Cephalalgia of results from its Phase II clinical study investigating the efficacy and ...

Avanir Pharmaceuticals and OptiNose Announce Development and Commercialization Agreement for a New Fast-Acting Sumatriptan Investigational Product for the Treatment of Acute Migraine New Drug ...

Sumatriptan 5mg, 20mg; per spray. The vascular 5-HT 1 receptor subtype to which sumatriptan binds selectively, and through which it presumably exerts its antimigrainous effect, is present on cranial ...

If sumatriptan isn’t working for your migraine symptoms, consider trying a different form of the medication, such as a nasal spray or injection. These options may be more effective as you absorb them ...

COLUMBUS, Ohio – A new study suggests that when over-the-counter medications fail to help children who suffer from chronic migraine headaches, those children may find relief with a drug traditionally ...

Migraine is one of the most frequent neurological disorders worldwide. The high prevalence of this disabling disease in the general population generates a strong medical imperative for the search for ...

Sumatriptan is a go-to prescription medication for many people battling acute migraine and cluster headaches. It works by targeting specific serotonin receptors to reduce pain and inflammation, and ...

It’s important to note that Imitrex is not approved to help prevent migraine or cluster headaches. The active drug in Imitrex is sumatriptan. And Imitrex is available as the generic drug sumatriptan.